HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Removing Pediatric OTC Cold Drugs Would Create New Problems – CHPA

This article was originally published in The Tan Sheet

Executive Summary

Pulling pediatric cough/cold products off the shelf in an effort to curb adverse events could lead to "unintended" consequences, such as parents inappropriately giving children adult medication, according to results of a Consumer Healthcare Products Association study

You may also be interested in...

Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking

As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary

Novartis Pediatric Triaminic Target Of Proposed Class Action

Novartis' Triaminic Daytime Cold & Cough, one of the OTC children's cold product lines voluntarily withdrawn from the market in 2007 due to concerns about misuse, is the subject of proposed class action

FDA Panel Narrowly Votes Against Cough/Cold Drugs For Children Up To Age 6

An FDA advisory panel decided in split votes Oct. 19 to recommend immediately that all OTC cough/cold medicines should not be used for 2-to 5-year-old children but are safe for 6- to 12-year-olds

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts